Emerging pharmacologic therapies for wet age-related macular degeneration.


As researchers and clinicians are beginning to understand that wet age-related macular degeneration (AMD) is more than simply a vascular disease that includes angiogenic, vascular and inflammatory components, they are exploring new agents with different mechanisms of action addressing multiple targets in this complex pathophysiology. Some of them are… (More)
DOI: 10.1159/000228926


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics